EBIT (Quarterly)

EBIT: Income before interest and taxes.

Bioventus Inc. (BVS) had EBIT of $8.42M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$132.09M
Net Income	$3.11M
Cost of Goods Sold	$41.32M
Gross Profit	$90.77M
Operating Expenses	$123.67M
Operating Income	$8.42M
Non-Operating Income/Expense	$-3.90M
Pre-Tax Income	$4.52M
Normalized Pre-Tax Income	$4.52M
Income after Taxes	$3.95M
Income from Continuous Operations	$3.95M
Consolidated Net Income/Loss	$3.95M
Normalized Income after Taxes	$3.95M
EBIT	$8.42M
EBITDA	$19.62M
Weighted-Average Shares Outstanding (Basic)	67.30M
Weighted-Average Shares Outstanding (Diluted)	70.01M
Earnings per Share (EPS) (Basic)	$0.05
Earnings per Share (EPS) (Diluted)	$0.04
Balance Sheet Financials
Current Assets	$249.81M
Property, Plant, and Equipment	$21.29M
Long-Term Assets	$400.73M
Total Assets	$650.54M
Current Liabilities	$148.09M
Long-Term Debt	$253.33M
Long-Term Liabilities	$268.18M
Total Liabilities	$416.27M
Common Equity	$234.26M
Tangible Shareholders Equity	$-132.86M
Shareholders Equity	$234.26M
Common Shares Outstanding	83.43M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$8.93M
Cash Flow from Investing Activities	$-0.57M
Cash Flow from Financial Activities	$-23.14M
Beginning Cash	$51.24M
End Cash	$35.85M
Increase/Decrease in Cash	$-15.39M
Stock-Based Compensation	$3.26M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.69
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.52
Debt to Equity Ratio	1.16
Gross Margin	68.72%
Operating Margin	6.37%
EBIT Margin	6.37%
EBITDA Margin	--
Pre-Tax Profit Margin	3.42%
Profit Margin	2.36%
Free Cash Flow	$8.36M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.20
Inventory Turnover	0.50
Receiveable Turnover	1.10
Days Sales in Receivables	82.12
Return on Equity	1.68%
Return on Tangible Equity	-2.97%
Return on Assets	0.61%
Return on Investments	0.81%
Book Value Per Share	$2.81
Free Cash Flow per Share	$0.12
Operating Cash Flow per Share	$0.13

Data from Zacks Investment Research, Inc.